MX9707191A - Compuesto triciclicos utiles para inhibir la funcion de la proteina g y para tratamiento de enfermedades proliferativas. - Google Patents

Compuesto triciclicos utiles para inhibir la funcion de la proteina g y para tratamiento de enfermedades proliferativas.

Info

Publication number
MX9707191A
MX9707191A MX9707191A MX9707191A MX9707191A MX 9707191 A MX9707191 A MX 9707191A MX 9707191 A MX9707191 A MX 9707191A MX 9707191 A MX9707191 A MX 9707191A MX 9707191 A MX9707191 A MX 9707191A
Authority
MX
Mexico
Prior art keywords
inhibition
treatment
alkyl
compounds useful
proliferative diseases
Prior art date
Application number
MX9707191A
Other languages
English (en)
Other versions
MXPA97007191A (es
Inventor
Adriano Afonso
Joseph M Kelly
Ronald L Wolin
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MX9707191A publication Critical patent/MX9707191A/es
Publication of MXPA97007191A publication Critical patent/MXPA97007191A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se da a conocer un método de inhibicion de la funcion del Ras y por lo tanto de inhibicion del crecimiento celular. El método comprende la administracion de un nuevo compuesto de la formula (Ia), (Ib) o (Ic) donde: R y R1 H, alquilo, halogeno, OH, alcoxi, NH2; alquilamino, dialquilamino; CF3; SO3H; CO2R3; NO2; SO2NH2; o CONHR4; n representa 0 o 1; R2 es un grupo de la formula R5C(O)-, R5CH2C(O)-, R5C(R6)2C(O)-, R5S=2-, R5CH2SO2-, R5SCH2C(O)-, R5OC(O)-, R5NHC(O)-, R5NHC(O)-, R5C(O)C(O)-, R5SC(O); R5 representa alquilo, arilo, arilalquilo, arilalquenilo, heteroarilo, heteroarilalquilo, heteroarilalquenilo o heterocicloalquilo; y R6 representa alquilo o C(R6)2 es un anillo carbocíclico; o sales farmacéuticamente aceptables de los mismos.
MXPA/A/1997/007191A 1995-03-24 1997-09-22 Compuesto triciclicos utiles para inhibir la funcion de la proteina g y para tratamiento de enfermedades proliferativas MXPA97007191A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/410,442 US5684013A (en) 1995-03-24 1995-03-24 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
US08410442 1995-03-24
PCT/US1996/003306 WO1996030017A1 (en) 1995-03-24 1996-03-20 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases

Publications (2)

Publication Number Publication Date
MX9707191A true MX9707191A (es) 1997-11-29
MXPA97007191A MXPA97007191A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
US5684013A (en) 1997-11-04
IL117603A0 (en) 1996-07-23
CA2216291C (en) 2001-06-05
US5703090A (en) 1997-12-30
EP0814807B1 (en) 2003-05-07
TW473477B (en) 2002-01-21
HUP9801396A3 (en) 2000-03-28
IL117603A (en) 2001-01-28
AU708244B2 (en) 1999-07-29
ES2198481T3 (es) 2004-02-01
AR003936A1 (es) 1998-09-30
NZ305133A (en) 1999-11-29
DE69627993T2 (de) 2004-02-26
JPH10505102A (ja) 1998-05-19
AU5307296A (en) 1996-10-16
DE69627993D1 (de) 2003-06-12
EP0814807A1 (en) 1998-01-07
ATE239472T1 (de) 2003-05-15
US5958939A (en) 1999-09-28
HUP9801396A2 (hu) 1999-05-28
KR19980703257A (ko) 1998-10-15
WO1996030017A1 (en) 1996-10-03
CA2216291A1 (en) 1996-10-03
JP3001982B2 (ja) 2000-01-24

Similar Documents

Publication Publication Date Title
CA2216291A1 (en) Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
CA2174105A1 (en) Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
IE900394L (en) Thiazole derivatives
CA2173963A1 (en) Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
WO1991013055A3 (en) New aryl- and heteroarylethenylene derivatives and process for their preparation
CA2269994A1 (en) 7-hetero-bicyclo¬2.2.1|-heptanes
TW359670B (en) Process for producing quinazolin-4-one derivatives
CA2160444A1 (en) Aroyl-piperdine derivatives
EP0322738A3 (en) Benzylidene-malononitrile derivatives for the inhibition of proliferative processes in mammalian cells
HU9202105D0 (en) Tetrahydro-pyrrholo(1,2-a)pyrazine-4-spiro-3'-pyrrholidine derivatives method for producing them and pharmaceutical preparatives containing them
MXPA02006329A (es) 8-arilquinolinas sustituidas que son inhibidores de fosfodiesterasa-4.
EP0825189A4 (en) 1,4-BENZODIOXIN DERIVATIVES
EP0335979A4 (en) Thienopyrimidine derivatives
IE64851B1 (en) New bronchospasmolytic compounds and process for their preparation
HK1034074A1 (en) 1,2-dihydro-2-oxoquinoline derivatives
ES2128960A1 (es) Derivados de fluorofenil-triazinas y pirimidinas compuestos farmacologicamente activos en el sistema nervioso central.
IE45096L (en) Thiadiazole derivatives
CA2293368A1 (en) Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives useful for inhibition of farnesyl protein transferase
ES8701144A1 (es) Un procedimiento para preparar un derivado de tetrahidronaf-taleno
DE3772852D1 (de) Thiadiazolylacetamid-derivate, verfahren zu ihrer herstellung und ihre verwendung.
HU9202849D0 (en) Method for producing n,n',n-trisubstituted- 5-bis-amino-methylene-1,3-dioxane-4,6-dione derivatives and pharmaceutical preparatives containing them
ATE260905T1 (de) (phenylalkylaminoalkyloxy)-hetero-aryl- verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CA2293373A1 (en) Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase
NO912341L (no) Fremgangsmaate for fremstilling av inhibitorer av hiv-revers transkiptase.
JO1635B1 (en) New compounds to shrink the people and a process to prepare them